Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mina Ying Min Wu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biotechnology Journal|September 3, 2025
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO CellsMina Ying Min Wu, Frances Rocamora, Caressa M Robinson, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO cellsMina Ying Min Wu, Frances Rocamora, Caressa M Robinson, et al.
Biotechnology Advances|June 24, 2023
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapiesFrances Rocamora, Angelo G Peralta, Seunghyeon Shin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Improving Recombinant Antibody Production Using FcBAR: An In Situ Approach to Detect and Amplify Protein-Protein InteractionsMina Ying Min Wu, Frances Rocamora, Mojtaba Samoudi, et al.
Metabolic Engineering|July 25, 2025
Improving recombinant antibody production using FcBAR: An in situ approach to detect and amplify protein-protein interactionsMina Ying Min Wu, Frances Rocamora, Mojtaba Samoudi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived proteinFrances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biotechnology Journal|September 3, 2025
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO CellsMina Ying Min Wu, Frances Rocamora, Caressa M Robinson, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO cellsMina Ying Min Wu, Frances Rocamora, Caressa M Robinson, et al.
Biotechnology Advances|June 24, 2023
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapiesFrances Rocamora, Angelo G Peralta, Seunghyeon Shin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Improving Recombinant Antibody Production Using FcBAR: An In Situ Approach to Detect and Amplify Protein-Protein InteractionsMina Ying Min Wu, Frances Rocamora, Mojtaba Samoudi, et al.
Metabolic Engineering|July 25, 2025
Improving recombinant antibody production using FcBAR: An in situ approach to detect and amplify protein-protein interactionsMina Ying Min Wu, Frances Rocamora, Mojtaba Samoudi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived proteinFrances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Pageof 1